(Q38067450)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23240753%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

review article

1 reference

title

Bone marrow transplantation in epidermolysis bullosa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23240753%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23240753%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

John Mcgrath

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23240753%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Alya Abdul-Wahab

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23240753%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

1 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23240753%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23240753%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23240753%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23240753%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

1859-1867

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23240753%20AND%20SRC:MED&resulttype=core&format=json

The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB

20 February 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Natural gene therapy in dystrophic epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Tissue form of type VII collagen from human skin and dermal fibroblasts in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: an EB-specific quality of life instrument.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Bone marrow transplantation for recessive dystrophic epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Bone marrow-derived cells contribute to epithelial engraftment during wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Bone marrow-derived keratinocytes are not detected in normal skin and only rarely detected in wounded skin in two different murine models.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Concise review: hitting the right spot with mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Immunomodulatory properties of mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Gene expression signatures of mouse bone marrow-derived mesenchymal stem cells in the cutaneous environment and therapeutic implications for blistering skin disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Non-herlitz junctional epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Herlitz junctional epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Native versus recombinant high-mobility group B1 proteins: functional activity in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Revertant mosaicism in skin: natural gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

SIN retroviral vectors expressing COL7A1 under human promoters for ex vivo gene therapy of recessive dystrophic epidermolysis bullosa

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Novel molecular therapies for heritable skin disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

PTC124-mediated translational readthrough of a nonsense mutation causing Usher syndrome type 1C.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Transdermal delivery of a readthrough-inducing drug: a new approach of gentamicin administration for the treatment of nonsense mutation-mediated disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Bone marrow stem cell therapy for recessive dystrophic epidermolysis bullosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

Isolation and cultivation of human keratinocytes from skin or plucked hair for the generation of induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FIMT.12.120

21 January 2018

Identifiers

DOI

10.2217/IMT.12.120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23240753%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference